Those are pharmacology results, not proof of a clinical benefit there is no controlled human trial showing CJC-1295 improves body composition, a disease outcome, or any functional measure, and the no-DAC form has no controlled human trials at all
[PubMed: 20203018] 261
SeekPeptides members frequently discuss strategies for optimizing body composition during this phase, including protein timing, resistance training protocols, and supplementation approaches that preserve lean mass while maximizing fat loss
For Ipamorelin, studies show strong GHreleasing potency with low activation of other hormones
Improved Sleep Quality: Research indicates that participants using Ipamorelin often report enhanced sleep patterns, a critical factor for overall recovery, hormonal equilibrium, and study integrity
Batch: GF-TESAIPA10/3-B242 Tesamorelin Assay: 10.90 mg Ipamorelin Assay: 3.57 mg Tesamorelin Purity: 99.7 percent Ipamorelin Purity: greater than 99.8 percent Tesamorelin Identification by RT: 0.991 Ipamorelin Identification by RT: 0.992 Molecular Ion Mass Identification (Tesamorelin): 5135 Da Molecular Ion Mass Identification (Ipamorelin): 993 Da Bacterial Endotoxins: 0.014 EU/mg Total Aerobic Microbial Count: Not detected Total Yeast and Mold Count: Not detected Research Applications In controlled laboratory environments, Tesamorelin / Ipamorelin may be utilised in experimental models designed to investigate peptide signalling systems and receptor interaction pathways
